CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.23, sa.5, ss.681-684, 2005 (SCI-Expanded)
Objective. To identify, the proportion of patients fulfilling the inclusion criteria widely used in most clinical trials for rheumatoid arthritis (RA) - including the recent clinical trials of anti-Tinnor Necrosis Factor a (TNF alpha) agents - in a Turkish cohort.